CN117137977A - Preparation method of lactation-promoting traditional Chinese medicine composition for sows - Google Patents
Preparation method of lactation-promoting traditional Chinese medicine composition for sows Download PDFInfo
- Publication number
- CN117137977A CN117137977A CN202311356669.XA CN202311356669A CN117137977A CN 117137977 A CN117137977 A CN 117137977A CN 202311356669 A CN202311356669 A CN 202311356669A CN 117137977 A CN117137977 A CN 117137977A
- Authority
- CN
- China
- Prior art keywords
- parts
- brown sugar
- promoting
- sows
- lactation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 72
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 30
- 229940079593 drug Drugs 0.000 claims abstract description 20
- 239000007788 liquid Substances 0.000 claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 11
- 238000002156 mixing Methods 0.000 claims abstract description 9
- 238000002791 soaking Methods 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims abstract description 8
- 240000007594 Oryza sativa Species 0.000 claims abstract description 7
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 7
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 7
- 235000009566 rice Nutrition 0.000 claims abstract description 7
- 238000010025 steaming Methods 0.000 claims abstract description 6
- 238000005303 weighing Methods 0.000 claims abstract description 6
- 238000009835 boiling Methods 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims abstract description 4
- 229910001220 stainless steel Inorganic materials 0.000 claims abstract description 4
- 239000010935 stainless steel Substances 0.000 claims abstract description 4
- 241000405414 Rehmannia Species 0.000 claims description 18
- 241000382455 Angelica sinensis Species 0.000 claims description 13
- 235000006533 astragalus Nutrition 0.000 claims description 12
- 210000000582 semen Anatomy 0.000 claims description 11
- 241000112528 Ligusticum striatum Species 0.000 claims description 9
- 241000045403 Astragalus propinquus Species 0.000 claims description 8
- 239000002245 particle Substances 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 39
- 230000001737 promoting effect Effects 0.000 abstract description 31
- 230000006651 lactation Effects 0.000 abstract description 23
- 230000036039 immunity Effects 0.000 abstract description 10
- 241001465754 Metazoa Species 0.000 abstract description 8
- 230000012010 growth Effects 0.000 abstract description 4
- 238000011084 recovery Methods 0.000 abstract description 4
- 208000035240 Disease Resistance Diseases 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 3
- 238000009395 breeding Methods 0.000 abstract description 3
- 230000001488 breeding effect Effects 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 238000009776 industrial production Methods 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 238000007605 air drying Methods 0.000 abstract 1
- 238000010298 pulverizing process Methods 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 18
- 239000008280 blood Substances 0.000 description 18
- 210000004185 liver Anatomy 0.000 description 11
- 238000011160 research Methods 0.000 description 11
- 230000002401 inhibitory effect Effects 0.000 description 10
- 230000007812 deficiency Effects 0.000 description 9
- 229920001282 polysaccharide Polymers 0.000 description 9
- 239000005017 polysaccharide Substances 0.000 description 9
- 150000004804 polysaccharides Chemical class 0.000 description 9
- CSJAXRKDCCWCSJ-UHFFFAOYSA-N Echinopsine Chemical compound C1=CC=C2N(C)C=CC(=O)C2=C1 CSJAXRKDCCWCSJ-UHFFFAOYSA-N 0.000 description 8
- FINHMKGKINIASC-UHFFFAOYSA-N Tetramethylpyrazine Chemical compound CC1=NC(C)=C(C)N=C1C FINHMKGKINIASC-UHFFFAOYSA-N 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 230000000144 pharmacologic effect Effects 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 7
- 230000002708 enhancing effect Effects 0.000 description 7
- 239000000341 volatile oil Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 6
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 206010042674 Swelling Diseases 0.000 description 5
- 229940107666 astragalus root Drugs 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 5
- 235000001785 ferulic acid Nutrition 0.000 description 5
- 229940114124 ferulic acid Drugs 0.000 description 5
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 230000002633 protecting effect Effects 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 241001061264 Astragalus Species 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010060710 Galactostasis Diseases 0.000 description 4
- 239000009636 Huang Qi Substances 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 229930013930 alkaloid Natural products 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 229930003935 flavonoid Natural products 0.000 description 4
- 235000017173 flavonoids Nutrition 0.000 description 4
- 150000002215 flavonoids Chemical class 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 208000004396 mastitis Diseases 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 4
- 230000035882 stress Effects 0.000 description 4
- 210000004233 talus Anatomy 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 206010021143 Hypoxia Diseases 0.000 description 3
- 208000019395 Lactation disease Diseases 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 206010042576 Suppressed lactation Diseases 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000000916 dilatatory effect Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000000242 pagocytic effect Effects 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- IQVQXVFMNOFTMU-FLIBITNWSA-N (Z)-ligustilide Chemical compound C1CC=CC2=C1C(=C/CCC)/OC2=O IQVQXVFMNOFTMU-FLIBITNWSA-N 0.000 description 2
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 2
- FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 2
- NOEGNKMFWQHSLB-UHFFFAOYSA-N 5-hydroxymethylfurfural Chemical compound OCC1=CC=C(C=O)O1 NOEGNKMFWQHSLB-UHFFFAOYSA-N 0.000 description 2
- 241000125175 Angelica Species 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241001480043 Arthrodermataceae Species 0.000 description 2
- UXDIXFDKSPCUIX-AXFHLTTASA-N Cnidilide Chemical compound C1=CCC[C@@H]2[C@H](CCCC)OC(=O)[C@@H]21 UXDIXFDKSPCUIX-AXFHLTTASA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 description 2
- 241000212322 Levisticum officinale Species 0.000 description 2
- UPJFTVFLSIQQAV-KOLCDFICSA-N Neocnidilide Chemical compound C1CC[C@H]2[C@H](CCCC)OC(=O)C2=C1 UPJFTVFLSIQQAV-KOLCDFICSA-N 0.000 description 2
- UPJFTVFLSIQQAV-UHFFFAOYSA-N Neocnidilide Natural products C1CCC2C(CCCC)OC(=O)C2=C1 UPJFTVFLSIQQAV-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241000727169 Prinsepia utilis Species 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- ZPIKVDODKLJKIN-NSHDSACASA-N Senkyunolide Chemical compound C1CC=CC2=C1[C@H](CCCC)OC2=O ZPIKVDODKLJKIN-NSHDSACASA-N 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
- IQVQXVFMNOFTMU-DHZHZOJOSA-N Z-ligustilide Natural products C1CC=CC2=C1C(=C/CCC)\OC2=O IQVQXVFMNOFTMU-DHZHZOJOSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000037006 agalactosis Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 2
- UXDIXFDKSPCUIX-UHFFFAOYSA-N condilide Natural products C1=CCCC2C(CCCC)OC(=O)C21 UXDIXFDKSPCUIX-UHFFFAOYSA-N 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 230000037304 dermatophytes Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000012173 estrus Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- RJGBSYZFOCAGQY-UHFFFAOYSA-N hydroxymethylfurfural Natural products COC1=CC=C(C=O)O1 RJGBSYZFOCAGQY-UHFFFAOYSA-N 0.000 description 2
- 230000007954 hypoxia Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000001645 levisticum officinale Substances 0.000 description 2
- OPMNROCQHKJDAQ-FKSUSPILSA-N loline Chemical compound C1C[C@@H]2O[C@H]3[C@H](NC)[C@@H]2N1C3 OPMNROCQHKJDAQ-FKSUSPILSA-N 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 210000002464 muscle smooth vascular Anatomy 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000036284 oxygen consumption Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- LZEPVVDVBJUKSG-UHFFFAOYSA-N pterocarpan Chemical compound C1=CC=C2C3COC4=CC=CC=C4C3OC2=C1 LZEPVVDVBJUKSG-UHFFFAOYSA-N 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- QBLFZIBJXUQVRF-UHFFFAOYSA-N (4-bromophenyl)boronic acid Chemical compound OB(O)C1=CC=C(Br)C=C1 QBLFZIBJXUQVRF-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010006298 Breast pain Diseases 0.000 description 1
- 206010006312 Breast swelling Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 102000006311 Cyclin D1 Human genes 0.000 description 1
- 108010058546 Cyclin D1 Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000132514 Echinops ritro Species 0.000 description 1
- 208000004145 Endometritis Diseases 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 208000001287 Galactorrhea Diseases 0.000 description 1
- 206010017600 Galactorrhoea Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102000000588 Interleukin-2 Human genes 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- QURCVMIEKCOAJU-HWKANZROSA-N Isoferulic acid Natural products COC1=CC=C(\C=C\C(O)=O)C=C1O QURCVMIEKCOAJU-HWKANZROSA-N 0.000 description 1
- 241000735234 Ligustrum Species 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 241001409305 Siraitia Species 0.000 description 1
- 229930187719 Soyasaponin Natural products 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 244000178320 Vaccaria pyramidata Species 0.000 description 1
- 235000010587 Vaccaria pyramidata Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229920001284 acidic polysaccharide Polymers 0.000 description 1
- 150000004805 acidic polysaccharides Chemical class 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 229960002319 barbital Drugs 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000001964 calcium overload Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000024203 complement activation Effects 0.000 description 1
- 102000006834 complement receptors Human genes 0.000 description 1
- 108010047295 complement receptors Proteins 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000816 effect on animals Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000000214 effect on organisms Effects 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- OPMNROCQHKJDAQ-UHFFFAOYSA-N festucine Natural products C1CC2OC3C(NC)C2N1C3 OPMNROCQHKJDAQ-UHFFFAOYSA-N 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 229940044627 gamma-interferon Drugs 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000001096 hypoplastic effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229930002839 ionone Natural products 0.000 description 1
- 150000002499 ionone derivatives Chemical class 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- -1 microelements Chemical compound 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 230000002232 neuromuscular Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 231100000255 pathogenic effect Toxicity 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- YQUVCSBJEUQKSH-UHFFFAOYSA-N protochatechuic acid Natural products OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229930183325 senkyunolide Natural products 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
- WKOLLVMJNQIZCI-UHFFFAOYSA-N vanillic acid Chemical compound COC1=CC(C(O)=O)=CC=C1O WKOLLVMJNQIZCI-UHFFFAOYSA-N 0.000 description 1
- TUUBOHWZSQXCSW-UHFFFAOYSA-N vanillic acid Natural products COC1=CC(O)=CC(C(O)=O)=C1 TUUBOHWZSQXCSW-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Abstract
The invention discloses a preparation method of a lactation promoting traditional Chinese medicine composition for sows, which belongs to the technical field of traditional Chinese veterinary medicines and comprises the following steps: weighing the raw materials; steaming brown sugar in basin, dissolving in warm water to obtain brown sugar water; mixing brown sugar water and yellow wine, soaking, air drying, and pulverizing into superfine powder; or mixing and dissolving the fermented glutinous rice juice and brown sugar, soaking the raw materials, adding water until all the materials are submerged, boiling in a sealed stainless steel pot, and taking the liquid medicine and the residues. The traditional Chinese medicine composition for promoting lactation of sows, which is prepared by the method, is prepared by reasonable formula of traditional Chinese medicines, and has no medicine residue and no toxic or side effect; the preparation method is simple and is suitable for the requirement of large-scale industrial production. The feed has the main effects of improving lactation yield and immunity of sows, promoting postpartum recovery, stress resistance and the like of sows, accelerating piglet growth, improving disease resistance of piglets, promoting early weaning of young animals, improving uniformity of young animals and finally improving economic benefits of breeding industry.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese veterinary medicines, and particularly relates to a preparation method of a lactation-promoting traditional Chinese medicine composition for sows.
Background
In livestock production, some sows are frequently in postpartum hypogalactia or weaning, the growth speed, the immunity, the weaning nest weight and the like of piglets are seriously influenced, the piglets are sick, grow slowly and grow stagnantly, and serious economic losses are brought to pig farmers. There are many reasons for the lack or lack of lactation in sows after delivery: 1. sow malnutrition, emaciation, weakness, body weakness and physiological hypofunction; the sow is overfertilized, and the breasts are filled with fat; the sow is premature in hybridization and the mammary gland is hypoplastic; the pregnant women are inappropriately fed, the expansion degree of breasts is poor before and after delivery, partial primary milk is available, but the lactation is not carried out soon; 2. the sow suffers from complications such as mastitis and endometritis after delivery, and has symptoms of anorexia, listlessness, breast red swelling, oliguria and agalactia. The sow is required to find out the reason and adopt proper measures to solve the problem of postpartum hypogalactia or agalactia.
Therefore, how to develop a method for preparing the lactation promoting traditional Chinese medicine composition for the sow, which can improve the lactation yield and the immunity of the sow, promote the postpartum recovery, the stress resistance and the like of the sow, accelerate the growth of piglets, improve the disease resistance of the piglets, promote the early weaning of young animals, improve the uniformity of the young animals and finally improve the economic benefit of the breeding industry, by reasonably screening and composing the traditional Chinese medicine, is a technical problem which needs to be solved by the technicians in the field.
Disclosure of Invention
Aiming at the defects of the prior art, the invention provides a preparation method of a lactation-promoting traditional Chinese medicine composition for sows, which solves the problem that the sows lack or have no lactation after delivery.
In order to achieve the above purpose, the invention is realized by the following technical scheme:
a preparation method of a lactation-promoting traditional Chinese medicine composition for sows comprises the following steps:
(1) Weighing the following raw material medicaments in part by weight: 3-6 parts of astragalus membranaceus, 3-6 parts of uniflower swisscentaury root, 3-6 parts of ligusticum wallichii, 3-6 parts of angelica sinensis, 3-6 parts of medulla tetrapanacis, 3-6 parts of semen vaccariae and 3-6 parts of prepared rehmannia root;
(2) Steaming brown sugar in basin, dissolving in 40-50deg.C warm water to obtain brown sugar water with brown sugar content of 5-20wt%;
(3) Mixing and soaking the crude drugs with brown sugar water and yellow wine according to the volume ratio of 10:3 for 24 hours, taking out the crude drugs, airing and crushing the crude drugs into superfine powder;
or mixing and dissolving the fermented glutinous rice juice and the brown sugar, soaking the raw material medicines for 48 hours, adding water until all the medicinal materials are submerged, adding 10L of the fermented glutinous rice juice into 1kg of brown sugar, boiling for 40 minutes by using a closed stainless steel pot, and taking the medicinal liquid and the medicinal residues.
Further, the weight portions of the raw materials are as follows: 3.5-6 parts of astragalus membranaceus, 3.5-6 parts of uniflower swisscentaury root, 3.5-6 parts of ligusticum wallichii, 3.5-6 parts of angelica sinensis, 3.5-6 parts of medulla tetrapanacis, 3.5-6 parts of semen vaccariae and 3.5-6 parts of prepared rehmannia root.
Further, the particle size of the ultrafine powder is 300 mesh or more.
Further, the dosage of the superfine powder is 200g of each pig, 1000g of the traditional Chinese medicine composition is diluted with 2-3 distilled water to be filled into each bag of the traditional Chinese medicine composition when the traditional Chinese medicine composition is used, and the traditional Chinese medicine composition is used for 3-5 days as a treatment course once a day;
or the dosage of the liquid medicine is 100mL of the liquid medicine per 100kg of the liquid medicine fed by the pig by weight, 2 times a day, 3-5 days for continuous feeding, and the corresponding medicine dreg mixed material is fed.
Modern pharmaceutical research shows that each medicine has the following effects:
1. astragalus root, radix astragali, sweet in taste and slightly warm in nature; the Chinese medicinal composition enters lung, spleen, liver and kidney meridians; has effects in invigorating qi, consolidating superficial resistance, inducing diuresis, relieving edema, removing toxic substances, promoting pus discharge, healing sore, promoting granulation, enhancing immunity, protecting liver, promoting urination, resisting aging and stress, lowering blood pressure, and inhibiting bacteria. The chemical components of radix astragali mainly comprise flavonoids, saponins and polysaccharides, wherein the flavonoids comprise four kinds of flavonoids, isoflavone and pterocarpan, and the saponins comprise radix astragali saponin and its soyasaponin. In addition, the composition also contains monosaccharide, amino acid, protein, riboflavin, folic acid, nicotinic acid, vitamin D, linoleic acid, linolenic acid, microelements, vanillic acid, ferulic acid, isoferulic acid, p-hydroxyphenyl acrylic acid, caffeic acid, chlorogenic acid, palmitic acid and the like. Modern pharmaceutical research shows that astragalus has various pharmacological actions: (1) enhancing the immunity of the organism: astragalus root can strengthen the phagocytic function of reticuloendothelial system, so that the number of blood leucocytes and polynuclear leucocytes is obviously increased, the phagocytic percentage and phagocytic index of macrophages are obviously increased, and the astragalus root has the effect of promoting humoral immunity and cellular immunity. Astragalus mongholicus also increases the activity of lymphokine (interleukin-2) activated natural killer cells (LAK). (2) enhancing the stress capability of the organism: the astragalus polysaccharide has obvious anti-fatigue effect, can obviously prolong the swimming time of hydrocortisone-depleted mice and increase the epinephrine weight, has obvious tolerance to various hypoxia models of the mice, and can obviously reduce systemic oxygen consumption and increase the hypoxia tolerance of tissues. The astragalus polysaccharide has obvious low temperature resistance, and can obviously prolong the antibiotic life of normal and deficiency mice. (3) promote metabolism and improve cardiac function. (4) liver protection and blood pressure reduction: astragalus root can prevent liver glycogen from decreasing and has a protective effect on carbon tetrachloride hepatitis of mice. (5) antibacterial and antiviral effects: radix astragali has inhibiting effects on Bacillus dysenteriae, pneumococcus, hemolytic streptococcus, golden yellow, lemon color, and white staphylococcus. Astragalus mongholicus has the capability of enhancing virus induced interferon and has a certain inhibition effect on pathogenic effects of oral viruses and influenza Sendai BB1 viruses, but has no direct inactivation effect.
2. Radix Rhapontici, bitter and salty in taste, and cold in nature; enter stomach and large intestine meridians. Has effects of clearing heat and detoxicating, dredging channels and promoting lactation, and can be used for treating acute mastitis, swelling and pain, galactostasis, carbuncle, skin sore, spasm of wet arthralgia and tendons, bone joint pain, and toxic heat and bloody dysentery. Modern researches have shown that the main components of uniflower swisscentaury root are: rhizoma Phragmitis, qizhou, contains volatile oil; the fruit of Echinops ritro L of Xinjiang contains Echinopsine, and the seed contains Echinopsine (Echinopsine) and Echinopsine (Echinine). Modern pharmaceutical research shows that the pharmacological actions of uniflower swisscentaury root are as follows: (1) effects on the central nervous system: the effect of the privet head alkali is similar to that of strychnine, the small dose has exciting effect on animals, the large dose causes spasm, and the systemic inhibition appears later; has effects in waking up mice sleep caused by barbital, exciting neuromuscular device, and promoting peripheral nerve recovery. (2) effects on the cardiovascular system: the prinsepia utilis can cause blood pressure drop and heart contractility increase for anesthetized cat, and heart contractility tension increase for isolated frog heart, contraction amplitude decrease, and high concentration can stop heart in systole. Exhibiting vasodilation to isolated rabbit ears. (3) effect on intestinal smooth muscle: the prinsepia utilis royle alkali can increase the tension of the cat in vitro intestinal canal and inhibit the rabbit in vitro intestinal canal. It is weaker in spasmolytic action than Shining. (4) antifungal action: the radix Rhapontici (unknown variety) water infusion (1:3) has various degrees of inhibition effects on dermatophytes such as Trichophyton schoenlafricanum and Nocardia astrotrichlica in vitro. Clinically, the uniflower swisscentaury root and a plurality of traditional Chinese medicines are used together, and can be used for treating initial sores and carbuncles, galactostasis, breast swelling and pain and other symptoms; can also be used for treating tumor, obesity, cystic hyperplasia of breast, etc.
3. Ligusticum wallichii, pungent in flavor and warm in nature; enter liver, gallbladder and pericardium meridians. Has effects of promoting blood circulation, activating qi-flowing, dispelling pathogenic wind, and relieving pain, and can be used for treating traumatic injury, qi and blood stasis, retention of placenta, puerperal blood stasis, and rheumatalgia. The active ingredients of rhizoma Ligustici Chuanxiong mainly include alkaloids such as ligustrazine (chuanxiongzine), loline (pelolyrine), and L-isoleucine-L-valine anhydride, organic acids and phenols such as ferulic acid (ferulic acid), siraitia acid, and chrysophanol, volatile oils such as ligustilide (ligustilide), cnidilide (cnidilide), neocnidilide (neocnidilide), and senkyunolide, and other ingredients. Modern pharmaceutical researches have shown that Ligusticum wallichii has the following pharmacological actions: (1) cardiovascular effects: the rhizoma Ligustici Chuanxiong water extract and alkaloid have effects of dilating coronary artery, increasing coronary artery flow, improving myocardial anoxia, and reducing myocardial oxygen consumption, and can be used for relieving coronary heart disease and angina pectoris. Is beneficial to playing the role of dilating blood vessels in brain, improving microcirculation, inhibiting platelet aggregation and the like. (2) antithrombotic action: ligustrazine can increase cAMP content in platelets, has inhibitory effect on thromboxane A2 (TXA 2) and alkaloids, can reduce platelet surface activity, inhibit platelet aggregation, and depolymerize aggregated platelets. Can shorten the length of thrombus, reduce the dry weight and wet weight of thrombus, and has certain curative effect on Diffuse Intravascular Coagulation (DIC). (3) spasmolytic and analgesic effects: chuan Xiong is water-extracted or alcohol-extracted extractum, which can inhibit the contraction of small intestine and uterus in vitro. Chuan (Chinese character)The volatile oil and decoction of rhizoma Ligustici Chuanxiong have tranquilizing effect, and the decoction can resist caffeine excitation. (4) antibacterial action: has obvious inhibiting effect on various gram-negative intestinal bacteria and inhibiting effect on various dermatophytes. In addition, researches show that the active ingredients of the ligusticum wallichii, such as ligustrazine, ferulic acid and the like, have the functions of scavenging oxygen free radicals and relieving Ca 2+ Overload, vascular endothelial cell protection, vascular dilation, apoptosis and hypertrophy inhibition, immune state regulation, platelet aggregation and thrombosis resistance, and multiple cytokine expression influence, thereby being capable of playing roles for multiple systems, multiple organs and multiple diseases.
4. Dang Gui is sweet and pungent in flavor and warm in nature; it enters liver, heart and spleen meridians. Has effects in replenishing blood, nourishing blood, promoting blood circulation, relieving pain, moistening dryness, and relieving constipation, and can be used for treating blood deficiency, fatigue, pain due to blood stasis, traumatic injury, carbuncle, swelling, sore, constipation, and fetal production. Modern pharmacological researches have further proved that Chinese angelica has the effects of promoting blood circulation, removing blood stasis, enriching blood, relieving pain and the like, and meanwhile, chinese angelica has the effects of resisting inflammation, scavenging oxygen free radicals, protecting liver, promoting bile flow, protecting kidney, enhancing immune function and the like. The medicinal chemistry research shows that the angelica mainly contains volatile oil, saccharides, amino acids, organic acids, flavonoids, coumarin, vitamins and other chemical components. (1) The volatile oil of Angelica sinensis is the main active part of the volatile oil for relieving spasm of vascular smooth muscle, wherein the activity of artemethide is strongest, and the mechanism of the volatile oil is probably to interfere with the metabolism of calcium ions in cells. (2) Ferulic acid has strong antioxidant and free radical scavenging effects, and has effects of inhibiting platelet aggregation, resisting thrombosis, inhibiting liver synthesis cholesterol, reducing blood lipid, improving atherosclerosis, resisting bacteria and viruses, regulating immunity, resisting myocardial ischemia, and resisting liver injury. (3) The saccharides contained in Angelica sinensis are mainly fructose, sucrose (40%) and acidic polysaccharide with complement activity. The radix Angelicae sinensis polysaccharide has effects of replenishing blood, regulating immunity and regulating metabolism. The Angelica sinensis polysaccharide can promote differentiation of pluripotent hematopoietic stem cells and CFU-GM layer, stimulate marrow granule single-line hematopoietic, and increase peripheral blood leukocyte. The angelica polysaccharide can regulate the complement receptor activity of lymphocyte membrane phase, strengthen lymphocyte immune response and have certain enhancement effect on organism immune function. When the recombinant strain returns to have strong capability of inducing gamma-interferon, the recombinant strain has an anti-tumor effect. (4) It also has antiinflammatory, analgesic, liver protecting, gallbladder function promoting, kidney and lung protecting effects.
5. Medulla Tetrapanacis has sweet and light taste and cold property; enter lung and stomach meridians. Has effects of clearing heat, promoting urination, and promoting lactation, and can be used for treating damp-heat in bladder, dysuria, and galactorrhea. Modern pharmaceutical researches show that the medulla of the medulla Junci contains 5.95% ash, 1.07% fat, 1.11% protein, 48.73% crude fiber, 5% pentosan and 28.04% uronic acid. Pharmacological experiments show that the medulla Tetrapanacis has better diuretic, anti-inflammatory and antipyretic effects. Especially, the medulla Tetrapanacis has rich polysaccharide content, and has certain effects of regulating immunity and resisting oxidation.
6. Semen Vaccariae, bitter in taste and mild in nature; enter liver and stomach meridians. Has the functions of dredging collaterals, promoting lactation, promoting blood circulation and removing blood stasis; is mainly used for treating galactostasis, acute mastitis and furuncle. The chemical components of the semen vaccariae mainly comprise triterpenoid saponins, flavonoid glycosides, coumarin and alkaloids. Has antioxidant, vascular smooth muscle dilating and angiogenesis inhibiting pharmacological activities; has pharmacological effects of resisting early pregnancy, resisting tumor, exciting uterus, promoting lactation, etc. Researches show that the Huang Tongzao glycoside component of the semen vaccariae is one of the effective components of the semen vaccariae, has the effect of promoting lactation, promotes proliferation of mammary epithelial cells of mice by inducing expression of cyclin D1, and induces expression of beta-casein genes by activating Jak-stat5 signaling pathway.
7. The prepared rehmannia root is a processed product of the dried rehmannia root, and after being processed, the medicine property is changed from slight cold to slight warm, so that the tonifying property is enhanced. Sweet taste and warm nature; it enters liver and kidney meridians. Has the effects of replenishing blood, nourishing essence, replenishing marrow, and is used for treating deficiency of liver-yin and kidney-yin, deficiency of blood, essence deficiency, flaccidity of waist and crotch, dyspnea due to deficiency, chronic cough, deficiency heat and night sweat. The chemical components in the prepared rehmannia root mainly comprise polysaccharide, 5-hydroxymethylfurfural, amino acid, iridoids, rehmannia root, mannitol, vitamin A substances, trihydroxy ionone and the like, and the chemical components are the material basis of pharmacological actions of the prepared rehmannia root. The prepared rehmannia root polysaccharide has the main functions of enhancing the hematopoiesis of organisms, enhancing the immunity of the organisms, resisting oxidation, resisting mutation and inhibiting the central nervous system. The prepared rehmannia root 5-hydroxymethyl furfural has the functions of resisting oxidation, improving hemorheology and the like. The prepared rehmannia root water extract can obviously stimulate Balb/C mice to secrete cytokine TNF-alpha, and the TNF-alpha has the killing activity and the anti-tumor activity on tumor cells, so that the prepared rehmannia root has the anti-tumor activity. The aqueous extract of radix rehmanniae Preparata not only can promote endothelial cell proliferation, but also can enhance memory and resist anxiety. In addition, researches show that the prepared rehmannia root ethanol extract has the functions of resisting aging and obviously promoting the regeneration of red blood cells, and improving the organism function deficiency caused by blood deficiency.
The traditional Chinese medicine composition has the following formula principle: the semen vaccariae in the prescription has the effects of promoting blood circulation, dredging channels, promoting lactation and relieving swelling, is a monarch drug and is mainly used for treating galactostasis, acute mastitis and furuncle; the Chinese angelica and the szechuan lovage rhizome have the effects of replenishing blood and activating blood, the astragalus and the prepared rehmannia root have the effects of tonifying qi and strengthening spleen, expelling toxin and expelling pus, and replenishing essence and marrow, and are ministerial drugs; radix Rhapontici has effects of removing toxic substances, resolving carbuncle, dredging channels and promoting lactation, and medulla Tetrapanacis has effects of activating collaterals, inducing diuresis and relieving swelling, and is used as adjuvant drug. The medicines are combined together to play the roles of tonifying qi, nourishing blood, dredging channels and promoting lactation. The compound feed has remarkable effects of preventing and treating hypogalactia of sows, has extremely remarkable lactation promoting effect by adopting the proportion described in the embodiment 3, and is particularly suitable for promoting lactation of sows.
The beneficial effects of the invention are as follows:
1. the traditional Chinese medicine composition soaked by brown sugar has obvious prevention and treatment effects on lack of lactation of sows and lack of lactation, and improves lactation yield by 5-15%.
2. Can effectively improve the immunity of the organism, promote the postpartum recovery of the sow, resist stress and the like.
3. Improving disease resistance of piglets, promoting early weaning of young animals, improving uniformity of young animals, accelerating growth of piglets, and finally improving economic benefit of breeding industry.
4. The traditional Chinese medicine composition is diluted with white spirit and boiled water until the liquid medicine can be filled, and the traditional Chinese medicine oral liquid has low or no residue in the pig body, is not easy to generate drug resistance and has good biological safety.
5. The invention has simple and reasonable formula, no medicine residue, no toxic or side effect, abundant traditional Chinese medicine resources, simple preparation method and low cost, and is suitable for the requirement of large-scale industrial production.
Detailed Description
The technical solutions of the embodiments of the present invention will be clearly and completely described below in conjunction with the embodiments of the present invention, and it is apparent that the described embodiments are only some embodiments of the present invention, not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
Example 1
The preparation method of the lactation-promoting traditional Chinese medicine composition for the sows comprises the following steps:
(1) Weighing the following raw material medicaments in part by weight: 3kg of astragalus membranaceus, 3kg of uniflower swisscentaury root, 3kg of szechuan lovage rhizome, 6kg of Chinese angelica, 6kg of medulla tetrapanacis, 6kg of semen vaccariae and 6kg of prepared rehmannia root;
(2) Steaming and dissolving brown sugar in basin, and dissolving in 40 deg.C warm water to obtain brown sugar water with brown sugar content of 5wt%;
(3) Mixing and soaking the crude drugs with brown sugar water and yellow wine according to the volume ratio of 10:3 for 24 hours, taking out the crude drugs, airing and crushing the crude drugs into superfine powder.
Example 2
The preparation method of the lactation-promoting traditional Chinese medicine composition for the sows comprises the following steps:
(1) Weighing the following raw material medicaments in part by weight: 3.5kg of astragalus membranaceus, 3.5kg of uniflower swisscentaury root, 3.5kg of ligusticum wallichii, 6kg of angelica sinensis, 6kg of medulla tetrapanacis, 6kg of semen vaccariae and 6kg of prepared rehmannia root;
(2) Steaming and dissolving brown sugar in a basin, and dissolving in warm water at 45 ℃ to obtain brown sugar water, wherein the content of brown sugar in the brown sugar water is 15wt%;
(3) Mixing and soaking the crude drugs with brown sugar water and yellow wine according to the volume ratio of 10:3 for 24 hours, taking out the crude drugs, airing and crushing the crude drugs into superfine powder.
Example 3
The preparation method of the lactation-promoting traditional Chinese medicine composition for the sows comprises the following steps:
(1) Weighing the following raw material medicaments in part by weight: astragalus root 4.5kg, uniflower swisscentaury root 4.5kg, ligusticum wallichii 4.5kg, chinese angelica root 4.5kg, medulla tetrapanacis 4.5kg, seed of cowherb 4.5kg, prepared rehmannia root 4.5kg;
(2) Steaming and dissolving brown sugar in basin, and dissolving in 50deg.C warm water to obtain brown sugar water with brown sugar content of 20wt%;
(3) Mixing and dissolving the fermented glutinous rice juice and the brown sugar, soaking the raw materials for 48 hours, adding water until all the materials are submerged, adding 10L of the fermented glutinous rice juice into 1kg of brown sugar, boiling for 40 minutes by using a closed stainless steel pot, and taking the liquid medicine and the medicinal residues.
The Chinese medicinal materials used in examples 1-3 all meet the standards of the second edition of the Chinese animal pharmacopoeia 2020.
The dosage of the superfine powder is 200g each pig, when the medicated bag is used, 1000g of the medicated composition is diluted with 2-3 distilled water to obtain medicinal liquid, and the medicinal liquid can be taken once a day for 3-5 days as a treatment course;
the dosage of the liquid medicine is 100mL of the liquid medicine is fed per 100kg of pigs by weight, 2 times per day, 3-5 days for continuous feeding, and the corresponding medicine dreg is mixed for feeding.
Clinical test example:
dosage of experimental and control groups:
the experimental group adopts the traditional Chinese medicine composition of the example 2, the dosage is 200g each pig, 1000g of the traditional Chinese medicine composition is diluted with 2-3 distilled spirit and warm boiled water for each bag when the traditional Chinese medicine composition is used, the traditional Chinese medicine composition can be taken after being filled with the liquid medicine, and the treatment course is 4 days after once a day.
The control group adopts the lactation promoting powder, the dosage is 40-60g for each pig, once a day, and 4 days are taken as a treatment course.
1. Test site: hebei Chengde Pingquan county;
2. test time: 2022, 11-12 months;
3. test animals: pig;
4. test results: see table 1 below.
TABLE 1 clinical trial results
| Test index | Experimental group | Control group |
| Total number of sows tested | 8 | 8 |
| Total number of parity | 93 | 92 |
| Number of head of live baby | 89 | 87 |
| Yield of live offspring (%) | 95.69 | 94.56 |
| Weight of primary nest (Kg) | 21.575 | 21.65 |
| Average birth weight (Kg/head) | 1.93 | 1.93 |
| Number of death in lactation period | 2 | 5 |
| Number of deaths at weaning | 1 | 3 |
| Number of weaning heads | 86 | 79 |
| Weaning nest weight (Kg) | 87.6 | 78.7 |
| Average weaning weight (Kg/head) | 8.15 | 7.97 |
| Sow weaning 10 days estrus mating number | 8 | 7 |
| Sow weaning 10 days oestrus mating rate (%) | 100 | 87.5 |
The description of the disclosed embodiments is provided to enable any person skilled in the art to make or use the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments without departing from the spirit or scope of the invention. Thus, the present invention is not intended to be limited to the embodiments shown herein but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Claims (4)
1. The preparation method of the lactation-promoting traditional Chinese medicine composition for the sows is characterized by comprising the following steps of:
(1) Weighing the following raw material medicaments in part by weight: 3-6 parts of astragalus membranaceus, 3-6 parts of uniflower swisscentaury root, 3-6 parts of ligusticum wallichii, 3-6 parts of angelica sinensis, 3-6 parts of medulla tetrapanacis, 3-6 parts of semen vaccariae and 3-6 parts of prepared rehmannia root;
(2) Steaming brown sugar in basin, dissolving in 40-50deg.C warm water to obtain brown sugar water with brown sugar content of 5-20wt%;
(3) Mixing and soaking the crude drugs with brown sugar water and yellow wine according to the volume ratio of 10:3 for 24 hours, taking out the crude drugs, airing and crushing the crude drugs into superfine powder;
or mixing and dissolving the fermented glutinous rice juice and the brown sugar, soaking the raw material medicines for 48 hours, adding water until all the medicinal materials are submerged, adding 10L of the fermented glutinous rice juice into 1kg of brown sugar, boiling for 40 minutes by using a closed stainless steel pot, and taking the medicinal liquid and the medicinal residues.
2. The preparation method of the lactation-promoting Chinese medicinal composition for sows as claimed in claim 1, wherein the raw materials comprise the following components in parts by weight: 3.5-6 parts of astragalus membranaceus, 3.5-6 parts of uniflower swisscentaury root, 3.5-6 parts of ligusticum wallichii, 3.5-6 parts of angelica sinensis, 3.5-6 parts of medulla tetrapanacis, 3.5-6 parts of semen vaccariae and 3.5-6 parts of prepared rehmannia root.
3. The method for preparing a lactating pharmaceutical composition for sow as claimed in claim 1, wherein the particle size of the superfine powder is more than 300 meshes.
4. The method for preparing the lactation-promoting Chinese medicinal composition for the sows, which is characterized in that the dosage of the superfine powder is 200g each time for each pig, and 1000g of the Chinese medicinal composition is diluted to liquid medicine with 2-3 white spirit and warm boiled water for each bag when the composition is used, and the liquid medicine can be taken once a day for 3-5 days as a treatment course;
or the dosage of the liquid medicine is 100mL of the liquid medicine per 100kg of the liquid medicine fed by the pig by weight, 2 times a day, 3-5 days for continuous feeding, and the corresponding medicine dreg mixed material is fed.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311356669.XA CN117137977A (en) | 2023-10-19 | 2023-10-19 | Preparation method of lactation-promoting traditional Chinese medicine composition for sows |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311356669.XA CN117137977A (en) | 2023-10-19 | 2023-10-19 | Preparation method of lactation-promoting traditional Chinese medicine composition for sows |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117137977A true CN117137977A (en) | 2023-12-01 |
Family
ID=88910302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202311356669.XA Pending CN117137977A (en) | 2023-10-19 | 2023-10-19 | Preparation method of lactation-promoting traditional Chinese medicine composition for sows |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN117137977A (en) |
-
2023
- 2023-10-19 CN CN202311356669.XA patent/CN117137977A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102178100B (en) | Low-tryptophan feed for hybrid chicken and preparation method of the low-tryptophan feed | |
| CN104173436A (en) | Compound traditional Chinese medicinal composition for cows, and preparation method and application thereof | |
| CN103690919B (en) | Medicine being used for the treatment of piglet iron-deficiency anemia and preparation method thereof | |
| CN102488848A (en) | Traditional Chinese medicine composition used for treating high-pathogenicity porcine reproductive and respiratory syndrome, preparation method thereof, and application thereof | |
| CN102743657B (en) | Traditional Chinese medicine composition for preventing piglet dysentery and preparation method thereof | |
| CN115969909B (en) | Traditional Chinese medicine composition and fermented traditional Chinese medicine preparation for improving sub-health of sow as well as preparation method and application of traditional Chinese medicine composition and fermented traditional Chinese medicine preparation | |
| CN107753636A (en) | A kind of compound Chinese herb powder for sows in perinatal period health care | |
| CN105833075A (en) | Traditional Chinese medicine preparation for preventing rabbit haemorrhagic diseases | |
| CN103239667B (en) | Chinese traditional medicine for treating foot-and-mouth disease of domestic animals | |
| CN114377095A (en) | Fructus amomi-sandalwood volatile oil extraction method, capsule for treating gastritis and preparation method of capsule | |
| CN117137977A (en) | Preparation method of lactation-promoting traditional Chinese medicine composition for sows | |
| CN108014301A (en) | A kind of Chinese medicine ferment for treating leukaemia and preparation method thereof | |
| CN103656048A (en) | Drug for treating cow mastitis and preparation method thereof | |
| CN103566312B (en) | Traditional Chinese medicine combination for treating loss of appetite of pigs | |
| CN103099885A (en) | Soft capsules having acne removing function and preparation method thereof | |
| KR101771521B1 (en) | Method of preparing oriental medicine composition for treating thyroid diseases | |
| CN104971294A (en) | Traditional Chinese medicine composition for preventing and treating cattle pneumonia and orally-taken preparation | |
| CN111084878A (en) | Biological medicine and medical total nutrient food for lung and respiratory system diseases and preparation method thereof | |
| CN111632080A (en) | Formula for treating drug eruption dermatitis, preparation method and application | |
| CN104173474A (en) | Traditional Chinese medicinal composition for improving reproductive function of sows, and preparation method thereof | |
| CN116942745B (en) | Traditional Chinese medicine composition for treating salpingitis of laying hens and preparation method thereof | |
| CN116350737B (en) | Composition for preventing cow fetal membranes from being damaged and preparation method thereof | |
| CN112439016B (en) | Traditional Chinese medicine composition for treating acute soft tissue injury, preparation method and application | |
| CN112402565B (en) | Traditional Chinese medicine composition for treating gonarthromeningitis and preparation method thereof | |
| CN112402566B (en) | Application of traditional Chinese medicine composition in preparation of medicine for treating gonarthromeningitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |